These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 29678111)
21. M Hassani SA; Neumann A; Russell J; Jones CK; Womelsdorf T Proc Natl Acad Sci U S A; 2023 May; 120(18):e2216792120. PubMed ID: 37104474 [TBL] [Abstract][Full Text] [Related]
26. Discovery of N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)isonicatinamide, ML293, as a novel, selective and brain penetrant positive allosteric modulator of the muscarinic 4 (M4) receptor. Salovich JM; Vinson PN; Sheffler DJ; Lamsal A; Utley TJ; Blobaum AL; Bridges TM; Le U; Jones CK; Wood MR; Daniels JS; Conn PJ; Niswender CM; Lindsley CW; Hopkins CR Bioorg Med Chem Lett; 2012 Aug; 22(15):5084-8. PubMed ID: 22738637 [TBL] [Abstract][Full Text] [Related]
27. Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias. van der Westhuizen ET; Choy KHC; Valant C; McKenzie-Nickson S; Bradley SJ; Tobin AB; Sexton PM; Christopoulos A Front Pharmacol; 2020; 11():606656. PubMed ID: 33584282 [TBL] [Abstract][Full Text] [Related]
28. Lead optimization of the VU0486321 series of mGlu1 PAMs. Part 1: SAR of modifications to the central aryl core. Garcia-Barrantes PM; Cho HP; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW Bioorg Med Chem Lett; 2015 Nov; 25(22):5107-10. PubMed ID: 26476971 [TBL] [Abstract][Full Text] [Related]
29. Development of Novel 4-Arylpyridin-2-one and 6-Arylpyrimidin-4-one Positive Allosteric Modulators of the M Jörg M; Khajehali E; van der Westhuizen ET; C Choy KH; Shackleford DM; Tobin AB; Sexton PM; Valant C; Capuano B; Christopoulos A; Scammells PJ ChemMedChem; 2021 Jan; 16(1):216-233. PubMed ID: 32851779 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen. Miller NR; Daniels RN; Bridges TM; Brady AE; Conn PJ; Lindsley CW Bioorg Med Chem Lett; 2008 Oct; 18(20):5443-7. PubMed ID: 18829311 [TBL] [Abstract][Full Text] [Related]
31. Development of VU6036864: A Triazolopyridine-Based High-Quality Antagonist Tool Compound of the M Li J; Orsi DL; Engers JL; Long MF; Capstick RA; Maurer MA; Presley CC; Vinson PN; Rodriguez AL; Han A; Cho HP; Chang S; Jackson M; Bubser M; Blobaum AL; Boutaud O; Nader MA; Niswender CM; Conn PJ; Jones CK; Lindsley CW; Han C J Med Chem; 2024 Aug; 67(16):14394-14413. PubMed ID: 39105778 [TBL] [Abstract][Full Text] [Related]
32. Persistent challenges in the development of an mGlu Kalbfleisch JJ; Rodriguez AL; Lei X; Weiss K; Blobaum AL; Boutaud O; Niswender CM; Lindsley CW Bioorg Med Chem Lett; 2023 Jan; 80():129106. PubMed ID: 36528230 [TBL] [Abstract][Full Text] [Related]
33. Muscarinic control of cardiovascular function in humans: a review of current clinical evidence. Palma JA Clin Auton Res; 2024 Feb; 34(1):31-44. PubMed ID: 38305989 [TBL] [Abstract][Full Text] [Related]
34. Spirocyclic replacements for the isatin in the highly selective, muscarinic M1 PAM ML137: the continued optimization of an MLPCN probe molecule. Poslusney MS; Melancon BJ; Gentry PR; Sheffler DJ; Bridges TM; Utley TJ; Daniels JS; Niswender CM; Conn PJ; Lindsley CW; Wood MR Bioorg Med Chem Lett; 2013 Mar; 23(6):1860-4. PubMed ID: 23416001 [TBL] [Abstract][Full Text] [Related]
35. Ligand-based virtual screen for the discovery of novel M5 inhibitor chemotypes. Geanes AR; Cho HP; Nance KD; McGowan KM; Conn PJ; Jones CK; Meiler J; Lindsley CW Bioorg Med Chem Lett; 2016 Sep; 26(18):4487-4491. PubMed ID: 27503678 [TBL] [Abstract][Full Text] [Related]
36. Design, Synthesis, and Characterization of Ogerin-Based Positive Allosteric Modulators for G Protein-Coupled Receptor 68 (GPR68). Yu X; Huang XP; Kenakin TP; Slocum ST; Chen X; Martini ML; Liu J; Jin J J Med Chem; 2019 Aug; 62(16):7557-7574. PubMed ID: 31298539 [TBL] [Abstract][Full Text] [Related]